한국어
English
日本語
中文(简体)
Equifin Film-Coated Tablet 50 mg (Safinamide Mesylate)
65.88mg
Tablet · Prescription medication
Korea Eisai Co., Ltd.
Safinamide mesylate is a central nervous system drug component used to improve the symptoms of Parkinson's disease.
MFDS ingredient code M278326
Safinamide mesylate is a pharmaceutical ingredient used in the treatment of Parkinson's disease and belongs to a class of other neuropharmaceuticals that act on the central nervous system. This ingredient is included in medications to alleviate motor function disorders.
Safinamide mesylate inhibits the breakdown of dopamine in the brain and regulates the balance of neurotransmitters, thereby improving motor control functions. Through this, it alleviates symptoms such as tremors and rigidity in patients with Parkinson's disease.
Approved uses differ by product. Check each product's information for its actual use.
Safinamide mesylate is differentiated from other Parkinson's disease treatments by its simultaneous inhibition of dopamine breakdown and regulation of neurotransmitters. This dual action can result in a variety of symptom improvement effects.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.